Celldex announced positive Phase I data for CDX-1401; CDC backs Tdap vaccination during every pregnancy;

 @AlisonBFierce: In search of a lasting flu vaccine: Researchers work to find decades of protection with one shot. More | Follow @AlisonBFierce

> Batches of the world's first vaccine against the hepatitis E virus began rolling out of a Chinese factory last week. News

> Celldex ($CLDX) announced positive results from a Phase I study of CDX-1401 in combination with TLR agonist resiquimod. Story

> A CDC panel backs Tdap vaccination during every pregnancy. Article

> Canada's top medical journal says hospitals should demand all doctors and healthcare workers be vaccinated against the flu. Item

And Finally... Developing countries are encountering challenges in terms of human resources, infrastructure and equipment costs in developing vaccines. Report

Suggested Articles

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.